Similar Stories to A Cancer Conundrum: Too Many Drug Trials, Too Few Patients on Bing News

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

Topics:  health   
RELATED ARTICLES
  • no title provided in feed
    The global fertility rate has fallen from 5 births per woman in 1950 to 2.3 in 2021 - and even lower in the U.S., partly due to the cost of child-rearing and shifts in priorities. But "falling population and an elderly or aging population puts a lot of fiscal and economic pressures on society," says Economics Professor Melissa Kearney. More
  • no title provided in feed
    Independent presidential candidate Robert F. Kennedy Jr. told The New York Times he experienced a series of health issues in recent years, including an abnormality that he said was caused by a worm that entered his brain and then died. More
  • no title provided in feed
    Americans' mental health issues are not identified and treated as readily as physical symptoms, especially among children - in part due to a shortage of clinicians. "We're looking for ways to integrate mental health into settings where children and families are every day," says Dr. More
  • no title provided in feed
    Mayor Donna Deegan speaks with CNN's Jake Tapper More
  • no title provided in feed
    Rep. Brad Wenstrup speaks with CNN's Jake Tapper More
  • no title provided in feed
    For some who see a therapist, just talking things through isn't enough. Drama therapy allows the patient to relive a moment or play out their biggest fears. More
BING NEWS:
  • New FDA Approvals: ASCO Session Reviews Uses and Adverse Effects
    The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
    06/1/2024 - 12:03 pm | View Link
  • Health News Highlights: Cancer Drug Trials, GenScript Scrutiny, and More
    This summary covers recent health news highlights, including Gilead's Trodelvy failing in a bladder cancer trial, Pfizer's optimistic sales forecast for Lorbrena, U.S. lawmakers' concerns about ...
    06/1/2024 - 9:58 am | View Link
  • Gilead drug fails to confirm its FDA approval in bladder cancer
    A Gilead drug has been approved for breast cancer, but the FDA could remove its approval in bladder cancer. It failed a late-stage trial earlier this year in a type of lung cancer.
    05/31/2024 - 10:55 am | View Link
  • Novartis leukemia drug more effective than older treatments in trial
    Swiss drugmaker Novartis said patients with a type of leukemia who took its Scemblix had a significantly better response and a lower dropout rate than those who received current standard-of-care drugs ...
    05/31/2024 - 12:16 am | View Link
  • Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
    Positive clinical trial results for a drug candidate to treat lung cancer sent shares of this unprofitable biotech firm soaring–and turbocharged Robert Duggan’s net worth.
    05/30/2024 - 6:47 pm | View Link
  • More